IDegAsp Shows Distinct Prandial and Basal Glucose-Lowering Effects at Steady State in Subjects With Type 1 Diabetes

被引：0
|
作者：
Heise, Tim
Nosek, Leszek
Hastrup, Hanne
Chenji, Suresh
Klein, Oliver
Haahr, Hanne
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
926-P
引用
收藏
页码：A235 / A235
页数：1
相关论文
共 50 条
  • [1] IDegAsp shows distinct prandial and basal glucose-lowering effects at steady state in subjects with type 1 diabetes
    Heise, T.
    Nosek, L.
    Hastrup, H.
    Chenji, S.
    Klein, O.
    Haahr, H.
    [J]. DIABETOLOGIA, 2013, 56 : S418 - S418
  • [2] Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus
    Tim Heise
    Leszek Nosek
    Carsten Roepstorff
    Suresh Chenji
    Oliver Klein
    Hanne Haahr
    [J]. Diabetes Therapy, 2014, 5 : 255 - 265
  • [3] Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus
    Heise, Tim
    Nosek, Leszek
    Roepstorff, Carsten
    Chenji, Suresh
    Klein, Oliver
    Haahr, Hanne
    [J]. DIABETES THERAPY, 2014, 5 (01) : 255 - 265
  • [4] Insulin degludec/insulin aspart in Japanese patients with type 1 diabetes mellitus: Distinct prandial and basal glucose-lowering effects
    Haahr, Hanne
    Sasaki, Tomio
    Bardtrum, Lars
    Ikushima, Ippei
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (04) : 574 - 580
  • [5] IDegAsp produces a dose-proportional glucose-lowering effect in subjects with type 1 diabetes
    Nosek, L.
    Heise, T.
    Klein, O.
    Coester, H. -V.
    Roepstorff, C.
    Svendsen, A.
    Haahr, H.
    [J]. DIABETOLOGIA, 2013, 56 : S418 - S419
  • [6] IDegAsp Produces Dose-Proportional Glucose-Lowering Effect in Subjects With Type 1 Diabetes
    Heise, Tim
    Nosek, Leszek
    Klein, Oliver
    Coester, Hans-Veit
    Roepstorff, Carsten
    Svendsen, Anne Louise
    Haahr, Hanne
    [J]. DIABETES, 2013, 62 : A241 - A241
  • [7] The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults are Preserved in Elderly Subjects With Type 1 Diabetes
    Pieber, Thomas
    Korsatko, Stefan
    Deller, Sigrid
    Kojzar, Harald
    Roepstorff, Carsten
    Svendsen, Anne Louise
    Haahr, Hanne
    [J]. DIABETES, 2013, 62 : A237 - A237
  • [8] The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes
    Martina Brunner
    Thomas Pieber
    Stefan Korsatko
    Harald Kojzar
    Anne Louise Svendsen
    Hanne Haahr
    [J]. Drugs & Aging, 2015, 32 : 583 - 590
  • [9] The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes
    Brunner, Martina
    Pieber, Thomas
    Korsatko, Stefan
    Kojzar, Harald
    Svendsen, Anne Louise
    Haahr, Hanne
    [J]. DRUGS & AGING, 2015, 32 (07) : 583 - 590
  • [10] INSULIN DEGLUDEC/INSULIN ASPART (IDEGASP) PRODUCES A DOSE-PROPORTIONAL GLUCOSE-LOWERING EFFECT IN SUBJECTS WITH TYPE 1 DIABETES
    Heise, T.
    Nosek, L.
    Coester, H.
    Klein, O.
    Roepstorff, C.
    Svendsen, A. L.
    Haahr, H.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S173 - S174
12345